Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression
NCT: NCT05371041 · ACTIVE_NOT_RECRUITING
Brief Summary
The investigators will implant and monitor 8 research subjects with a subcortical closed-loop system for detection and suppression of tics in subjects with medically refractory debilitating Tourette Syndrome. The project will use the FDA-approved "Medtronic Percept PC" device, which is an implantable neurostimulator capable of recording neural signals. The study will target the CM nucleus of the thalamus and the aGPi in each brain hemisphere from each subject and we will connect the two leads placed in each brain hemisphere to two Percept devices.
Frequently Asked Questions
What is Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression?
Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression is a clinical trial registered under NCT05371041. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05371041?
The current status of NCT05371041 (Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression) is: ACTIVE_NOT_RECRUITING.
When did Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression start?
Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression started on 2022-06-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.